Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Open Access Gateway

Activation of Signaling Cascades by Weak Extremely Low Frequency Electromagnetic Fields

Kapri-Pardes E.a · Hanoch T.a · Maik-Rachline G.a · Murbach M.b · Bounds P.L.b · Kuster N.b,c · Seger R.a

Author affiliations

aDepartment of Biological Regulation, the Weizmann Institute of Science, Rehovot, Israel
bFoundation for Research on Information Technologies in Society (IT’IS), Zurich, Switzerland
cSwiss Federal Institute of Technology (ETH) Zurich, Zurich, Switzerland

Corresponding Author

Rony Seger

Department of Biological Regulation Weizmann Institute of Science,

Rehovot (Israel)

Tel. 972-8-934-3602 Fax 972-8-9344186, E-Mail rony.seger@weizmann.ac.il

Related Articles for ""

Cell Physiol Biochem 2017;43:1533–1546

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

Background/Aims: Results from recent studies suggest that extremely low frequency magnetic fields (ELF-MF) interfere with intracellular signaling pathways related to proliferative control. The mitogen-activated protein kinases (MAPKs), central signaling components that regulate essentially all stimulated cellular processes, include the extracellular signal-regulated kinases 1/2 (ERK1/2) that are extremely sensitive to extracellular cues. Anti-phospho-ERK antibodies serve as a readout for ERK1/2 activation and are able to detect minute changes in ERK stimulation. The objective of this study was to explore whether activation of ERK1/2 and other signaling cascades can be used as a readout for responses of a variety of cell types, both transformed and non-transformed, to ELF-MF. Methods: We applied ELF-MF at various field strengths and time periods to eight different cell types with an exposure system housed in a tissue culture incubator and followed the phosphorylation of MAPKs and Akt by western blotting. Results: We found that the phosphorylation of ERK1/2 is increased in response to ELF-MF. However, the phosphorylation of ERK1/2 is likely too low to induce ELF-MF-dependent proliferation or oncogenic transformation. The p38 MAPK was very slightly phosphorylated, but JNK or Akt were not. The effect on ERK1/2 was detected for exposures to ELF-MF strengths as low as 0.15 µT and was maximal at ∼10 µT. We also show that ERK1/2 phosphorylation is blocked by the flavoprotein inhibitor diphenyleneiodonium, indicating that the response to ELF-MF may be exerted via NADP oxidase similar to the phosphorylation of ERK1/2 in response to microwave radiation. Conclusions: Our results further indicate that cells are responsive to ELF-MF at field strengths much lower than previously suspected and that the effect may be mediated by NADP oxidase. However, the small increase in ERK1/2 phosphorylation is probably insufficient to affect proliferation and oncogenic transformation. Therefore, the results cannot be regarded as proof of the involvement of ELF-MF in cancer in general or childhood leukemia in particular.

© 2017 The Author(s). Published by S. Karger AG, Basel


References

  1. Schuz J, Dasenbrock C, Ravazzani P, Roosli M, Schar P, Bounds PL, Erdmann F, Borkhardt A, Cobaleda C, Fedrowitz M, Hamnerius Y, Sanchez-Garcia I, Seger R, Schmiegelow K, Ziegelberger G, Capstick M, Manser M, Muller M, Schmid CD, Schurmann D, Struchen B, Kuster N: Extremely low-frequency magnetic fields and risk of childhood leukemia: A risk assessment by the ARIMMORA consortium. Bioelectromagnetics 2016; 37: 183-189.
  2. Anderson LE, Bailey WH, Blackman CF, Day NE, DelPizzo V, Guénel P, Hansson K, Hatch E, Juutilainen, J, Kheifets LI, Liboff AR, McCormick DL, Mevissen M, Miyakoshi J, Olsen JH, Portier CJ, Saunders RD, Schüz J, Stolwijk JAJ, Stuchly MA, Veyret B: Non-ionizing radiation, Part 1: Static and extremely low-frequency (ELF) electric and magnetic fields. IARC monographs 80 on the evaluation of carcinogenic risks to humans. Lyon France,IARC press,2002.
    External Resources
  3. Grellier J, Ravazzani P, Cardis E: Potential health impacts of residential exposures to extremely low frequency magnetic fields in Europe. Environ Int 2014; 62: 55-63.
  4. Repacholi M: Concern that “EMF” magnetic fields from power lines cause cancer. Sci Total Environ 2012; 426: 454-458.
  5. Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP: Preventable exposures associated with human cancers. J Natl Cancer Inst 2011; 103: 1827-1839.
  6. Buffler PA, Kwan ML, Reynolds P, Urayama KY: Environmental and genetic risk factors for childhood leukemia: appraising the evidence. Cancer Invest 2005; 23: 60-75.
  7. Valberg PA, Kavet R, Rafferty CN: Can low-level 50/60 Hz electric and magnetic fields cause biological effects? Radiat Res 1997; 148: 2-21.
  8. Cadossi R, Bersani F, Cossarizza A, Zucchini P, Emilia G, Torelli G, Franceschi C: Lymphocytes and low-frequency electromagnetic fields. FASEB J 1992; 6: 2667-2674.
    External Resources
  9. Funk RH, Monsees T, Ozkucur N: Electromagnetic effects - From cell biology to medicine. Prog Histochem Cytochem 2009; 43: 177-264.
  10. Maes A, Verschaeve L: Genetic damage in humans exposed to extremely low-frequency electromagnetic fields. Arch Toxicol 2016; 90: 2337-2348.
  11. Grassi C, D’Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A, Azzena GB: Effects of 50 Hz electromagnetic fields on voltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium 2004; 35: 307-315.
  12. Du L, Fan H, Miao H, Zhao G, Hou Y: Extremely low frequency magnetic fields inhibit adipogenesis of human mesenchymal stem cells. Bioelectromagnetics 2014; 35: 519-530.
  13. Delle Monache S, Angelucci A, Sanita P, Iorio R, Bennato F, Mancini F, Gualtieri G, Colonna RC: Inhibition of angiogenesis mediated by extremely low-frequency magnetic fields (ELF-MFs). PLoS One 2013; 8:e79309.
  14. Hisamitsu T, Narita K, Kasahara T, Seto A, Yu Y, Asano K: Induction of apoptosis in human leukemic cells by magnetic fields. Jpn J Physiol 1997; 47: 307-310.
  15. Yoon S, Seger R: The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 2006; 24: 21-44.
  16. Bersani F, Marinelli F, Ognibene A, Matteucci A, Cecchi S, Santi S, Squarzoni S, Maraldi NM: Intramembrane protein distribution in cell cultures is affected by 50 Hz pulsed magnetic fields. Bioelectromagnetics 1997; 18: 463-469.
  17. Hu GL, Chiang H, Zeng QL, Fu YD: ELF magnetic field inhibits gap junctional intercellular communication and induces hyperphosphorylation of connexin43 in NIH3T3 cells. Bioelectromagnetics 2001; 22: 568-573.
  18. Plotnikov A, Zehorai E, Procaccia S, Seger R: The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta 2011; 1813: 1619-1633.
  19. Uckun FM, Kurosaki T, Jin J, Jun X, Morgan A, Takata M, Bolen J, Luben R: Exposure of B-lineage lymphoid cells to low energy electromagnetic fields stimulates Lyn kinase. J Biol Chem 1995; 270: 27666-27670.
  20. Lindstrom E, Still M, Mattsson MO, Mild KH, Luben RA: ELF magnetic fields initiate protein tyrosine phosphorylation of the T cell receptor complex. Bioelectrochemistry 2001; 53: 73-78.
  21. Ke XQ, Sun WJ, Lu DQ, Fu YT, Chiang H: 50-Hz magnetic field induces EGF-receptor clustering and activates RAS. Int J Radiat Biol 2008; 84: 413-420.
  22. Thumm S, Loschinger M, Glock S, Hammerle H, Rodemann HP: Induction of cAMP-dependent protein kinase A activity in human skin fibroblasts and rat osteoblasts by extremely low-frequency electromagnetic fields. Radiat Environ Biophys 1999; 38: 195-199.
  23. He YL, Liu DD, Fang YJ, Zhan XQ, Yao JJ, Mei YA: Exposure to extremely low-frequency electromagnetic fields modulates Na+ currents in rat cerebellar granule cells through increase of AA/PGE2 and EP receptor-mediated cAMP/PKA pathway. PLoS One 2013; 8:e54376.
  24. Korzh-Sleptsova IL, Lindstrom E, Mild KH, Berglund A, Lundgren E: Low frequency MFs increased inositol 1, 4,5-trisphosphate levels in the Jurkat cell line. FEBS Lett 1995; 359: 151-154.
  25. Zhou J, Yao G, Zhang J, Chang Z: CREB DNA binding activation by a 50-Hz magnetic field in HL60 cells is dependent on extra- and intracellular Ca(2+) but not PKA, PKC, ERK, or p38 MAPK. Biochem Biophys Res Commun 2002; 296: 1013-1018.
  26. Martinez MA, Ubeda A, Cid MA, Trillo MA: The proliferative response of NB69 human neuroblastoma cells to a 50 Hz magnetic field is mediated by ERK1/2 signaling. Cell Physiol Biochem 2012; 29: 675-686.
  27. Huang CY, Chang CW, Chen CR, Chuang CY, Chiang CS, Shu WY, Fan TC, Hsu IC: Extremely low-frequency electromagnetic fields cause G1 phase arrest through the activation of the ATM-Chk2-p21 pathway. PLoS One 2014; 9:e104732.
  28. Flipo D, Fournier M, Benquet C, Roux P, Le Boulaire C, Pinsky C, LaBella FS, Krzystyniak K: Increased apoptosis, changes in intracellular Ca2+, and functional alterations in lymphocytes and macrophages after in vitro exposure to static magnetic field. J Toxicol Environ Health A 1998; 54: 63-76.
  29. Keshet Y, Seger R: The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. Methods Mol Biol 2010; 661: 3-38.
  30. Piala AT, Humphreys JM, Goldsmith EJ: MAP kinase modules: the excursion model and the steps that count. Biophys J 2014; 107: 2006-2015.
  31. Risso G, Blaustein M, Pozzi B, Mammi P, Srebrow A: Akt/PKB: one kinase, many modifications. Biochem J 2015; 468: 203-214.
  32. Toker A, Marmiroli S: Signaling specificity in the Akt pathway in biology and disease. Adv Biol Regul 2014; 55: 28-38.
  33. Martinez MA, Ubeda A, Moreno J, Trillo MA: Power frequency magnetic fields affect the p38 MAPK-mediated regulation of NB69 cell proliferation implication of free radicals. Int J Mol Sci 2016; 17: 510. DOI:10.3390/ijms17040510.
  34. Patruno A, Pesce M, Grilli A, Speranza L, Franceschelli S, De Lutiis MA, Vianale G, Costantini E, Amerio P, Muraro R, Felaco M, Reale M: mTOR activation by PI3K/Akt and ERK signaling in short ELF-EMF exposed human keratinocytes. PLoS One 2015; 10:e0139644.
  35. Nie K, Henderson A: MAP kinase activation in cells exposed to a 60 Hz electromagnetic field. J Cell Biochem 2003; 90: 1197-1206.
  36. Jin M, Blank M, Goodman R: ERK1/2 phosphorylation, induced by electromagnetic fields, diminishes during neoplastic transformation. J Cell Biochem 2000; 78: 371-379.
  37. Sun W, Chiang H, Fu Y, Lu D, Xu Z: Effects of electromagnetic noise on the enhancement of stress-activated protein kinase(SAPK) phosphorylation induced by 50 Hz magnetic fields. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002; 20: 246-248.
    External Resources
  38. Sun W, Yu Y, Chiang H, Fu Y, Lu D: Exposure to power-frequency magnetic fields can induce activation of P38 mitogen-activated protein kinase. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002; 20: 252-255.
    External Resources
  39. Sun W, Yu Y, Fu Y, Chiang H, Xie H, Lu D: Effects of power-frequency magnetic fields exposure on phosphorylation and enzymatic activity of stress-activated protein kinase and its upstream kinase. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002; 20: 256-259.
    External Resources
  40. Buldak RJ, Polaniak R, Buldak L, Zwirska-Korczala K, Skonieczna M, Monsiol A, Kukla M, Dulawa-Buldak A, Birkner E: Short-term exposure to 50 Hz ELF-EMF alters the cisplatin-induced oxidative response in AT478 murine squamous cell carcinoma cells. Bioelectromagnetics 2012; 33: 641-651.
  41. Yung Y, Dolginov Y, Yao Z, Rubinfeld H, Michael D, Hanoch T, Roubini E, Lando Z, Zharhary D, Seger R: Detection of ERK activation by a novel monoclonal antibody. FEBS lett 1997; 408: 292-296.
  42. Shaul YD, Seger R: The MEK/ERK cascade: From signaling specificity to diverse functions. Biochim Biophys Acta 2007; 1773: 1213-1226.
  43. Schuderer J, Oesch W, Felber N, Spat D, Kuster N: In vitro exposure apparatus for ELF magnetic fields. Bioelectromagnetics 2004; 25: 582-591.
  44. Chuderland D, Konson A, Seger R: Identification and characterization of a general nuclear translocation signal in signaling proteins. Mol Cell 2008; 31: 850-861.
  45. Yao Z, Seger R: The molecular mechanism of MAPK/ERK inactivation. Current Genomics 2004; 5: 385-393.
    External Resources
  46. Flores K, Seger R: Stimulated nuclear import by β-like importins. F1000Prime Reports 2013; 5: 41. DOI: 10.12703/P12705-12741.
  47. Friedman J, Kraus S, Hauptman Y, Schiff Y, Seger R: Mechanism of short-term ERK activation by electromagnetic fields at mobile phone frequencies. Biochem J 2007; 405: 559-568.
  48. Erdal N, Erdal ME, Gurgul S: Lack of effect of extremely low frequency electromagnetic fields on cyclin-dependent kinase 4 inhibitor gene p18(INK4C) in electric energy workers. Arch Med Res 2005; 36: 120-123.
  49. Maik-Rachline G, Seger R: The ERK cascade inhibitors: Towards overcoming resistance. Drug Resist Updat 2016; 25: 1-12.
  50. Liedvogel M, Mouritsen H: Cryptochromes–a potential magnetoreceptor: what do we know and what do we want to know? J R Soc Interface 2010; 7:S147-162.
  51. Lin FJ, Song W, Meyer-Bernstein E, Naidoo N, Sehgal A: Photic signaling by cryptochrome in the Drosophila circadian system. Mol Cell Biol 2001; 21: 7287-7294.
  52. Fogle KJ, Parson KG, Dahm NA, Holmes TC: CRYPTOCHROME is a blue-light sensor that regulates neuronal firing rate. Science 2011; 331: 1409-1413.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: September 21, 2016
Accepted: August 10, 2017
Published online: October 16, 2017
Issue release date: November 2017

ISSN: 1015-8987 (Print)
eISSN: 1421-9778 (Online)

For additional information: https://www.karger.com/CPB


Open Access License / Drug Dosage / Disclaimer

This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.